Sorry, you need to enable JavaScript to visit this website.

Boulder, Colorado

Boulder, CO Site Statistics

  • 4.5-acre site with more than 150,000-square-feet of state-of-the-art facilities featuring specialized laboratories and equipment
  • Joined Pfizer in 2019; the facility brings together nearly 300 employees
  • Located in the heart of Boulder near the prestigious University of Colorado Boulder and the picturesque Flatirons

Functions: Enzymology and Structural Biology, Cell Biology, Biostatistics, Medicinal Chemistry, Clinical Sciences and Operations, Commercial, Diagnostics, Drug Metabolism and Pharmacokinetics, Drug Safety, Early Clinical Development, Manufacturing, Medical Affairs, Medical Writing, Pharmaceutical Sciences, Pharmacology, Toxicology Quality, Regulatory, Translational Biology

Primary Therapeutic Areas: Oncology

Key Technologies: Structural and Computational Biology, Analytical Chemistry, Computational Chemistry, Proteomics, Spray-Dried Dispersions, Advanced Formulations

History and Overview:
In July 2019, Pfizer acquired Array BioPharma Inc., a Boulder-based biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. Following the acquisition of Array, Pfizer Boulder R&D joined the company’s vast network of research units, helping to enhance Pfizer’s Oncology franchise.

Pfizer Boulder’s expertise is in small molecule drug discovery, and the team has a successful track record in targeting the very important RAS/RAF/MEK/ERK signaling pathway, which is central to many types of cancer. Over the past two decades, the Boulder team has built an outstanding reputation in drug discovery and development, including filing 27 investigational new drug applications with the U.S. Food and Drug Administration (FDA).

When the site became part of Pfizer, it brought a compelling existing portfolio, including the combination of BRAFTOVI® and MEKTOVI®. In April 2020, the FDA also granted approval of BRAFTOVI in combination with cetuximab for an additional indication. Additionally, Pfizer Boulder scientists are proud to have played a significant role in the discovery, development, or both, of several royalty-generating, out-licensed medicines, including a number of novel tyrosine kinase inhibitors that address significant unmet needs across many types of cancer.

Currently, the Boulder pipeline has a promising range of potentially first- and best-in-class programs that may advance the next wave of innovative cancer treatments, including several next-generation, targeted molecules that may have the potential to penetrate the blood brain barrier.

PGS St. Louis, Mo.
PGS St. Louis, MO
In St. Louis, Meridian Medical Technologies produces innovative emergency care products that serve unique needs during severe medical crises.
PGS Sanford, N.C.
PGS Sanford, NC
The 230-acre site in Sanford, just south of the famed Research Triangle, is home to one of the largest U.S. biotechnology hubs.
PGS Rocky Mount, N.C.
PGS Rocky Mount, NC
The Rocky Mount site is one of the largest sterile injectable facilities in the world, with more than 1.4 million square feet of manufacturing space on 250 acres in Eastern North Carolina.
St. Louis, MO
A 300,000 sq. ft. facility producing innovative emergency care products that serve unique needs during severe medical crises
PGS Rochester, Mich.
PGS Rochester, MI
In Rochester, King Pharmaceuticals, a subsidiary of Pfizer, manufactures and packages penicillin, the only approved treatment for late stage syphilis.
Sandwich, UK
Home of the Pharmaceutical Sciences and Global Regulatory Affairs groups
PGS Pearl River, N.Y. 454 x 605
PGS Pearl River, NY
With more than 100 years of rich history in innovation and manufacturing excellence, 19 products- including various vaccines, antibiotics, and oncology medicines, have been discovered, developed, and approved at the Pearl River, New York site.
Pearl River
Pearl River, New York
The primary location for our company’s global Vaccine Research and Development work
La Jolla, California
Powerfully reinforcing the company's presence in the global biotechnology industry
Groton, Connecticut
Where nearly every one of our products are, in part, developed
Cambridge, Massachusetts
Global headquarters for our Center for Therapeutic Innovation (CTI), which has established locations in New York City, San Diego, and San Francisco
PGS Middleton, Wis. 454x605
PGS Middleton, WI
Since 1982, the Middleton site has focused on the manufacture of biologics. The 83,000-square-foot facility isolates bovine thrombin, a naturally occurring enzyme which plays a critical role in rapid clotting (hemostasis) of blood.